CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update Life Science Investing
Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update Pharmaceutical Investing
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 Life Science Investing
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases Biotech Investing
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates Pharmaceutical Investing
